FDA OKs Novavax COVID Vaccine as First Booster Shot


Share post:

By Cara Murez 

HealthDay Reporter

THURSDAY, Oct. 20, 2022 (HealthDay Information) – People will now have one other selection if they need a COVID booster shot.

On Wednesday, the U.S. Meals and Drug Administration accredited Novavax Inc.’s protein-based vaccine as a primary booster dose. Till now, it had solely been accredited as a two-dose main collection.

“The U.S. now has entry to the Novavax COVID-19 Vaccine, adjuvanted, the primary protein-based choice, as a booster,” Novavax President and CEO Stanley Erck stated in a information launch. “In response to CDC knowledge, nearly 50 % of adults who obtained their main collection have but to obtain their first booster dose. Providing one other vaccine selection could assist improve COVID-19 booster vaccination charges for these adults.”

The Novavax booster could possibly be utilized by adults who can’t discover or usually are not in a position to make use of an mRNA boosters from Pfizer or Moderna. It’s additionally out there to individuals who want this vaccine for a booster over the mRNA choices. The Novavax booster will be given not less than six months after the first collection.

The Novavax vaccine makes use of a extra conventional strategy to combating the virus, educating the immune system to acknowledge modified fragments of the coronavirus spike protein.

Scientists created the vaccine from a genetic sequence of the unique pressure of the virus. Vaccines that battle hepatitis B and pertussis are additionally made on this approach.

Public well being officers are encouraging folks to get their boosters. About 68% of U.S. residents have had an preliminary COVID vaccine collection, however solely 33.5% have obtained boosters, CDC knowledge reveals. Novavax’s vaccine is certainly one of 4 choices out there in the US now.

Extra data

The U.S. Facilities for Illness Management and Prevention has extra on COVID-19 vaccines.




Supply hyperlink


Please enter your comment!
Please enter your name here


Related articles